Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 12, Supplement A, 1983   [Index by Author] 


Down Preface
Down Articles
Down Index


[Search ALL Issues]


Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface Back

Harold Lambert, Ian Phillips, and Richard Wise
Preface
J. Antimicrob. Chemother. 1983 12: iii; doi:10.1093/jac/12.suppl_A.iii [PDF] [Request Permissions]  

Articles Back

B. I. Davies, F. P. V. Maesen, and J. A. van Noord
Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime
J. Antimicrob. Chemother. 1983 12: 1-8; doi:10.1093/jac/12.suppl_A.1 [Abstract] [PDF] [Request Permissions]  

Lionel A. Mandell, Lindsay E. Nicolle, Allan R. Ronald, Raymond Duperval, Hugh G. Robson, Ronald Feld, Jean Vincelette, and Ignatius Fong
A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia
J. Antimicrob. Chemother. 1983 12: 9-20; doi:10.1093/jac/12.suppl_A.9 [Abstract] [PDF] [Request Permissions]  

T. H. Peirce, S. J. Vig, and Patricia M. Ingram
Ceftazidime in the treatment of lower respiratory tract infection
J. Antimicrob. Chemother. 1983 12: 21-25; doi:10.1093/jac/12.suppl_A.21 [Abstract] [PDF] [Request Permissions]  

G. R. Keeton, B. Kehoe, S. W. Phillips, and H. Daya
Ceftazidime and cefamandole in the treatment of pneumonia
J. Antimicrob. Chemother. 1983 12: 27-30; doi:10.1093/jac/12.suppl_A.27 [Abstract] [PDF] [Request Permissions]  

Tor Pettersson, Eivor Storgårds, and Paavo Ahvonen
Treatment of lower respiratory tract infections with ceftazidime
J. Antimicrob. Chemother. 1983 12: 31-34; doi:10.1093/jac/12.suppl_A.31 [Abstract] [PDF] [Request Permissions]  

N. Vetter, H. Feist, F. Muhar, and K. J. Williams
A comparative study of the efficacy of ceftazidime versus cefazolin and tobramycin in patients with acute exacerbations of chronic bronchitis
J. Antimicrob. Chemother. 1983 12: 35-39; doi:10.1093/jac/12.suppl_A.35 [Abstract] [PDF] [Request Permissions]  

Kurt G. Naber, Frieder Kees, and Horst Grobecker
Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections
J. Antimicrob. Chemother. 1983 12: 41-45; doi:10.1093/jac/12.suppl_A.41 [Abstract] [PDF] [Request Permissions]  

Clair E. Cox
A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections
J. Antimicrob. Chemother. 1983 12: 47-52; doi:10.1093/jac/12.suppl_A.47 [Abstract] [PDF] [Request Permissions]  

Layne O. Gentry, Mark B. Douthit, Stacy J. Childs, and Paul O. Madsen
A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection
J. Antimicrob. Chemother. 1983 12: 53-57; doi:10.1093/jac/12.suppl_A.53 [Abstract] [PDF] [Request Permissions]  

L. H. Loebis and K. J. Williams
Ceftazidime in the treatment of complicated respiratory and urinary tract infections
J. Antimicrob. Chemother. 1983 12: 59-64; doi:10.1093/jac/12.suppl_A.59 [Abstract] [PDF] [Request Permissions]  

Nobuo Kawamura
Clinical experience with ceftazidime in urology in Japan
J. Antimicrob. Chemother. 1983 12: 65-70; doi:10.1093/jac/12.suppl_A.65 [Abstract] [PDF] [Request Permissions]  

S. J. Childs, S. Mirelman, and W. G. Wells
Perioperative use of ceftazidime as a prophylactic agent in transurethral surgery
J. Antimicrob. Chemother. 1983 12: 71-76; doi:10.1093/jac/12.suppl_A.71 [Abstract] [PDF] [Request Permissions]  

Paul O. Madsen and Paul Chr. Frimodt-Møller
Complicated urinary tract infections treated with ceftazidime and tobramycin: a comparative study
J. Antimicrob. Chemother. 1983 12: 77-79; doi:10.1093/jac/12.suppl_A.77 [Abstract] [PDF] [Request Permissions]  

Reuben Ramphal, Barnett S. Kramer, Kenneth H. Rand, Roy S. Weiner, and Joseph W. Shands, Jr.
Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients
J. Antimicrob. Chemother. 1983 12: 81-88; doi:10.1093/jac/12.suppl_A.81 [Abstract] [PDF] [Request Permissions]  

J. T. Reilly, M. Brada, A. J. Bellingham, C. A. Hart, and C. Bennet
Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients
J. Antimicrob. Chemother. 1983 12: 89-92; doi:10.1093/jac/12.suppl_A.89 [Abstract] [PDF] [Request Permissions]  

B. E. de Pauw, F. Kauw, H. Muytjens, K. J. Williams, and Th. Bothof
Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients
J. Antimicrob. Chemother. 1983 12: 93-99; doi:10.1093/jac/12.suppl_A.93 [Abstract] [PDF] [Request Permissions]  

V. Fainstein, G. P. Bodey, L. Elting, R. Bolivar, M. J. Keating, K. B. McCredie, and M. Valdivieso
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients
J. Antimicrob. Chemother. 1983 12: 101-110; doi:10.1093/jac/12.suppl_A.101 [Abstract] [PDF] [Request Permissions]  

K. Alestig, T. Eilard, R. Norrby, R. Svensson, B. Trollfors, and J. E. Brorson
Ceftazidime in clinical practice
J. Antimicrob. Chemother. 1983 12: 111-114; doi:10.1093/jac/12.suppl_A.111 [Abstract] [PDF] [Request Permissions]  

A. J. Bint, J. Constable, K. R. Patton, and F. L. Constable
Ceftazidime therapy for serious infections
J. Antimicrob. Chemother. 1983 12: 115-121; doi:10.1093/jac/12.suppl_A.115 [Abstract] [PDF] [Request Permissions]  

Kyuya Ishibiki
Clinical evaluation of ceftazidime in Japan
J. Antimicrob. Chemother. 1983 12: 123-130; doi:10.1093/jac/12.suppl_A.123 [Abstract] [PDF] [Request Permissions]  

R. A. Walstad, K. B. Hellum, P. L. Svarva, and Patricia M. Ingram
The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients
J. Antimicrob. Chemother. 1983 12: 131-137; doi:10.1093/jac/12.suppl_A.131 [Abstract] [PDF] [Request Permissions]  

P. Francioli, M. Clément, S. Geroulanos, A. von Graevenitz, R. Luthy, C. Regamey, H. Stalder, M. Vogt, and F. A. Waldvogel
Ceftazidime in severe infections: a Swiss multicentre study
J. Antimicrob. Chemother. 1983 12: 139-146; doi:10.1093/jac/12.suppl_A.139 [Abstract] [PDF] [Request Permissions]  

A. M. A. Abbas, M. C. Taylor, D. Newby, R. B. Jones, C. C. Rigby, A. R. Haste, and A. M. Cantor
Ceftazidime: a new approach in the treatment of moderate and severe infections
J. Antimicrob. Chemother. 1983 12: 147-152; doi:10.1093/jac/12.suppl_A.147 [Abstract] [PDF] [Request Permissions]  

E. Bouza, T. Hellín, J. Sanz-Hospital, M. Rodríguez-Creixems, E. Loza, and J. Martínez-Beltrán
Evaluation of ceftazidime in the treatment of severe bacterial infection
J. Antimicrob. Chemother. 1983 12: 153-159; doi:10.1093/jac/12.suppl_A.153 [Abstract] [PDF] [Request Permissions]  

Lawrence J. Eron, Choong H. Park, Deborah L. Hixon, Robin I. Goldenberg, and Donald M. Poretz
Ceftazidime in patients with pseudomonas infections
J. Antimicrob. Chemother. 1983 12: 161-169; doi:10.1093/jac/12.suppl_A.161 [Abstract] [PDF] [Request Permissions]  

A. Gasparetto and G. Delogu
Ceftazidime, as a single antibiotic, in the treatment of multi-resistant Gram-negative infections in intensive care
J. Antimicrob. Chemother. 1983 12: 171-175; doi:10.1093/jac/12.suppl_A.171 [Abstract] [PDF] [Request Permissions]  

C. Gravert, E. Schulz, and K. Sack
Ceftazidime in intensive care medicine and haemofiltration
J. Antimicrob. Chemother. 1983 12: 177-180; doi:10.1093/jac/12.suppl_A.177 [Abstract] [PDF] [Request Permissions]  

Jean-Claude Pechère and Réjean Delisle
Open study of ceftazidime in serious infections due to multiply-resistant bacteria
J. Antimicrob. Chemother. 1983 12: 181-188; doi:10.1093/jac/12.suppl_A.181 [Abstract] [PDF] [Request Permissions]  

R. van Dalen, H. L. Muytjens, and J. S. F. Gimbrère
Ceftazidime treatment in intensive care patients
J. Antimicrob. Chemother. 1983 12: 189-197; doi:10.1093/jac/12.suppl_A.189 [Abstract] [PDF] [Request Permissions]  

Per Lundbergh, Connie Jarstrand, Linda Morfeldt-Månson, and Ola Weiland
Ceftazidime in septicaemia
J. Antimicrob. Chemother. 1983 12: 199-205; doi:10.1093/jac/12.suppl_A.199 [Abstract] [PDF] [Request Permissions]  

N. Clumeck, B. Gordts, I. Dab, N. Jaspar, Y. Van Laethem, and J. P. Butzler
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections
J. Antimicrob. Chemother. 1983 12: 207-211; doi:10.1093/jac/12.suppl_A.207 [Abstract] [PDF] [Request Permissions]  

Melanie J. Maslow, Amy Rosenberg, Alan A. Pollock, Robert A. Press, David Silverman, Wafaa El-Sadr, Alma S. Richmond, Michael S. Simberkoff, and James J. Rahal, Jr.
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1983 12: 213-217; doi:10.1093/jac/12.suppl_A.213 [Abstract] [PDF] [Request Permissions]  

Harald Schoengut and Robert Jelinek
Comparative study of the effects of ceftazidime compared with tobramycin plus cefamandole in the treatment of gall bladder empyema
J. Antimicrob. Chemother. 1983 12: 219-222; doi:10.1093/jac/12.suppl_A.219 [Abstract] [PDF] [Request Permissions]  

J. C. Pottage, Jr, P. H. Karakusis, R. M. Fliegelman, S. Levin, and G. M. Trenholme
Ceftazidime in the therapy of serious Gram-negative bacillary infections
J. Antimicrob. Chemother. 1983 12: 223-228; doi:10.1093/jac/12.suppl_A.223 [Abstract] [PDF] [Request Permissions]  

J. P. Dutoy and G. Wauters
The treatment of bone infections with ceftazidime
J. Antimicrob. Chemother. 1983 12: 229-233; doi:10.1093/jac/12.suppl_A.229 [Abstract] [PDF] [Request Permissions]  

H. Warns, H. Lode, C. M. Harnoss, B. Kemmerich, P. Koeppe, and J. Wagner
Multiple dose pharmacokinetics and therapeutic results with ceftazidime
J. Antimicrob. Chemother. 1983 12: 235-240; doi:10.1093/jac/12.suppl_A.235 [Abstract] [PDF] [Request Permissions]  

D. Höffler, P. Koeppe, and K. J. Williams
The pharmacokinetics of ceftazidime in normal and impaired renal function
J. Antimicrob. Chemother. 1983 12: 241-245; doi:10.1093/jac/12.suppl_A.241 [Abstract] [PDF] [Request Permissions]  

F. D. Daschner, E. E. Petersen, H.-M. Just, and H. G. Hillemanns
Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue
J. Antimicrob. Chemother. 1983 12: 247-249; doi:10.1093/jac/12.suppl_A.247 [Abstract] [PDF] [Request Permissions]  

A. W. Mondorf, J. E. Scherberich, G. Heinert, and W. Schoeppe
Enzymuria: a parameter for the assessment of potential nephrotoxicity of cephalosporins
J. Antimicrob. Chemother. 1983 12: 251-254; doi:10.1093/jac/12.suppl_A.251 [Abstract] [PDF] [Request Permissions]  

Atsushi Saito
Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan
J. Antimicrob. Chemother. 1983 12: 255-262; doi:10.1093/jac/12.suppl_A.255 [Abstract] [PDF] [Request Permissions]  

A. Tourkantonis and P. Nicolaidis
Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis
J. Antimicrob. Chemother. 1983 12: 263-267; doi:10.1093/jac/12.suppl_A.263 [Abstract] [PDF] [Request Permissions]  

D. Adam, B. Reichart, and K. J. Williams
Penetration of ceftazidime into human tissue in patients undergoing cardiac surgery
J. Antimicrob. Chemother. 1983 12: 269-273; doi:10.1093/jac/12.suppl_A.269 [Abstract] [PDF] [Request Permissions]  

R. A. Walstad, K. B. Hellum, S. Blika, L. G. Dale, T. Fredriksen, K. I. Myhre, and G. R. Spencer
Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid
J. Antimicrob. Chemother. 1983 12: 275-282; doi:10.1093/jac/12.suppl_A.275 [Abstract] [PDF] [Request Permissions]  

Birgitta Strandvik, Anna-Stina Malmborg, Hans Alfredson, and Annika Ericsson
Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis
J. Antimicrob. Chemother. 1983 12: 283-287; doi:10.1093/jac/12.suppl_A.283 [Abstract] [PDF] [Request Permissions]  

Carolyn M. Kercsmar, Robert C. Stern, Michael D. Reed, Carolyn M. Myers, D. Murdell, and Jeffrey L. Blumer
Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response
J. Antimicrob. Chemother. 1983 12: 289-295; doi:10.1093/jac/12.suppl_A.289 [Abstract] [PDF] [Request Permissions]  

G. Mastella, M. Agostini, G. Barlocco, U. Bonomi, G. Borgo, L. Bozzino, G. Cabrini, L. M. Cappelletti, L. Castellani, M. Conforti, S. Marazzani, N. Martini, P. Montemezzi, G. Paulon, F. Pederzini, L. Sancassani, and G. Scroccaro
Alternative antibiotics for the treatment of pseudomonas infections in cystic fibrosis
J. Antimicrob. Chemother. 1983 12: 297-311; doi:10.1093/jac/12.suppl_A.297 [Abstract] [PDF] [Request Permissions]  

Henrik Permin, Christian Koch, Niels Heiby, Hans Ole Christensen, Alice Friis Møller, and Susanne Møller
Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis
J. Antimicrob. Chemother. 1983 12: 313-323; doi:10.1093/jac/12.suppl_A.313 [Abstract] [PDF] [Request Permissions]  

J. Dodge, I. Zamiri, Mary Goodchild, and Patricia Ingram
Experience with ceftazidime in cystic fibrosis
J. Antimicrob. Chemother. 1983 12: 325-329; doi:10.1093/jac/12.suppl_A.325 [Abstract] [PDF] [Request Permissions]  

Ronald Gold, Edward Jin, Henry Levison, Alan Isles, and Peter C. Fleming
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia
J. Antimicrob. Chemother. 1983 12: 331-336; doi:10.1093/jac/12.suppl_A.331 [Abstract] [PDF] [Request Permissions]  

T. J. David, Barbara M. Phillips, and P. J. Connor
Ceftazidime—a significant advance in the treatment of cystic fibrosis
J. Antimicrob. Chemother. 1983 12: 337-340; doi:10.1093/jac/12.suppl_A.337 [Abstract] [PDF] [Request Permissions]  

B. M. Assael, A. Boccazzi, M. L. Caccamo, A. Giunta, A. Marini, R. Padoan, F. Rusconi, and F. Sereni
Clinical pharmacology of ceftazidime in paediatrics
J. Antimicrob. Chemother. 1983 12: 341-346; doi:10.1093/jac/12.suppl_A.341 [Abstract] [PDF] [Request Permissions]  

G. Morgan, B. I. Duerden, and J. S. Lilleyman
Ceftazidime as a single agent in the management of children with fever and neutropenia
J. Antimicrob. Chemother. 1983 12: 347-351; doi:10.1093/jac/12.suppl_A.347 [Abstract] [PDF] [Request Permissions]  

S. Snelling, C. A. Hart, and R. W. I. Cooke
Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old
J. Antimicrob. Chemother. 1983 12: 353-356; doi:10.1093/jac/12.suppl_A.353 [Abstract] [PDF] [Request Permissions]  

P. J. Darbyshire, P. J. Williamson, S. J. Pedler, D. C. E. Speller, M. G. Mott, and A. Oakhill
Ceftazidime in the treatment of febrile immunosuppressed children
J. Antimicrob. Chemother. 1983 12: 357-360; doi:10.1093/jac/12.suppl_A.357 [Abstract] [PDF] [Request Permissions]  

J. G. Prinsloo, S. D. Delport, Joan Moncrieff, and Alexandra M. Paton
A preliminary pharmacokinetic studyn of ceftazidime in premature, new born and small infants
J. Antimicrob. Chemother. 1983 12: 361-364; doi:10.1093/jac/12.suppl_A.361 [Abstract] [PDF] [Request Permissions]  

P. Lautala, M. Vare, O. Vuorinen, and M.-L. Kaar
Ceftazidime in the treatment of chronic suppurative otitis media in children
J. Antimicrob. Chemother. 1983 12: 365-367; doi:10.1093/jac/12.suppl_A.365 [Abstract] [PDF] [Request Permissions]  

R. T. Cullen, W. M. McCrae, J. Govan, J. A. Raeburn, and Tricia M. Ingram
Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies
J. Antimicrob. Chemother. 1983 12: 369-375; doi:10.1093/jac/12.suppl_A.369 [Abstract] [PDF] [Request Permissions]  

Issei Nakayama
Clinical studies on ceftazidime in surgery in Japan
J. Antimicrob. Chemother. 1983 12: 377-381; doi:10.1093/jac/12.suppl_A.377 [Abstract] [PDF] [Request Permissions]  

Zenjiro Takase
Experience with ceftazidime in obstetrics and gynaecology in Japan
J. Antimicrob. Chemother. 1983 12: 383-387; doi:10.1093/jac/12.suppl_A.383 [Abstract] [PDF] [Request Permissions]  

J. K. Wardle, M. H. Snow, H. R. Ingham, and J. B. Selkon
An open study of the use of ceftazidime in Gram-negative infections
J. Antimicrob. Chemother. 1983 12: 389-393; doi:10.1093/jac/12.suppl_A.389 [Abstract] [PDF] [Request Permissions]  

Kaoru Shimada
Clinical evaluation of ceftazidime in internal medicine in Japan
J. Antimicrob. Chemother. 1983 12: 395-397; doi:10.1093/jac/12.suppl_A.395 [Abstract] [PDF] [Request Permissions]  

Roy D. Foord
Ceftazidime: aspects of efficacy and tolerance
J. Antimicrob. Chemother. 1983 12: 399-403; doi:10.1093/jac/12.suppl_A.399 [Abstract] [PDF] [Request Permissions]  

S. Ragnar Norrby
Ceftazidime in clinical practice — A summary
J. Antimicrob. Chemother. 1983 12: 405-408; doi:10.1093/jac/12.suppl_A.405 [PDF] [Request Permissions]  

Index Back

Index
J. Antimicrob. Chemother. 1983 12: 409-414; doi:10.1093/jac/12.suppl_A.409 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.